Clinical Trial Update: Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating an antibody conditioning regimen for allogeneic donor stem cell transplantation in patients with Fanconi anemia and severe aplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Fanconi Anemia

Snippet

Sponsor: Baylor College of Medicine | Conditions: Fanconi Anemia, Severe Aplastic Anemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-08-09